Vascular pharmacology of acute lung injury and acute respiratory distress syndromeGROENEVELD, A. B.Vascular pharmacology. 2002, Vol 39, Num 4-5, pp 247-256, issn 1537-1891, 10 p.Article

Clinically relevant end points and new drug approvals for myelomaANDERSON, K. C; KYLE, R. A; RAJKUMAR, S. V et al.Leukemia. 2008, Vol 22, Num 2, pp 231-239, issn 0887-6924, 9 p.Article

Gastrointestinal stromal tumors (GISTs) : focus on histopathological diagnosis and biomolecular featuresBADALAMENTI, G; RODOLICO, V; PANTUSO, G et al.Annals of oncology. 2007, Vol 18, issn 0923-7534, vi136-vi140, SUP6Conference Paper

Monoclonal antibodies in the treatment of multiple myelomaRICHARDSON, Paul G; LONIAL, Sagar; JAKUBOWIAK, Andrzej J et al.British journal of haematology. 2011, Vol 154, Num 6, pp 745-754, issn 0007-1048, 10 p.Article

Diabetes Mellitus in the Next Decade: Novel Pipeline Medications to Treat HyperglycemiaFONSECA, Vivian.Clinical therapeutics. 2013, Vol 35, Num 5, pp 714-723, issn 0149-2918, 10 p.Conference Paper

Is atrial fibrillation an inflammatory disorder?BOOS, Christopher J; ANDERSON, Richard A; LIP, Gregory Y. H et al.European heart journal. 2006, Vol 27, Num 2, pp 136-149, issn 0195-668X, 14 p.Article

Molecular biology of bone remodeling: Implications for new therapeutic targets for osteoporosisGALLAGHER, J. Chris; SAI, A. J.Maturitas (Amsterdam). 2010, Vol 65, Num 4, pp 301-307, issn 0378-5122, 7 p.Article

Novel therapeutic targets for erectile dysfunctionWILLIAMS, Steve K; MELMAN, Arnold.Maturitas (Amsterdam). 2012, Vol 71, Num 1, pp 20-27, issn 0378-5122, 8 p.Article

Targeted therapy in uterine serous carcinoma: an aggressive variant of endometrial cancerBLACK, Jonathan D; ENGLISH, Diana P; ROQUE, Dana M et al.Women's health (London. Print). 2014, Vol 10, Num 1, pp 45-57, issn 1745-5057, 13 p.Article

Systemic Therapy for Advanced Soft Tissue Sarcomas: Highlighting Novel Therapies and Treatment ApproachesRIEDEL, Richard F.Cancer. 2012, Vol 118, Num 6, pp 1474-1485, issn 0008-543X, 12 p.Article

Bone marrow microenvironment and the identification of new targets for myeloma therapyPODAR, K; CHAUHAN, D; ANDERSON, K. C et al.Leukemia. 2009, Vol 23, Num 1, pp 10-24, issn 0887-6924, 15 p.Article

Lupus Nephritis: The Evolving Role of Novel TherapeuticsROVIN, Brad H; PARIKH, Samir V.American journal of kidney diseases. 2014, Vol 63, Num 4, pp 677-690, issn 0272-6386, 14 p.Article

Bone marrow microenvironment and the identification of new targets for myeloma therapyPODAR, K; CHAUHAN, D; ANDERSON, K. C et al.Leukemia. 2008, issn 0887-6924, R131-R145, NSArticle

Topical agents for idiopathic distal colitis and proctitisLAWRANCE, Ian Craig.Journal of gastroenterology and hepatology. 2011, Vol 26, Num 1, pp 36-43, issn 0815-9319, 8 p.Article

Preclinical efficacy of the bioreductive alkylating agent RH I against paediatric tumoursHUSSEIN, D; HOLT, S. V; BROOKES, K. E et al.British journal of cancer. 2009, Vol 101, Num 1, pp 55-63, issn 0007-0920, 9 p.Article

Animal models for evaluating antiepileptogenesisWHITE, H. Steve.Epilepsia (Copenhagen). 2010, Vol 51, issn 0013-9580, p. 87, SUP5Conference Paper

Telomerase inhibition, telomere shortening, cell growth suppression and induction of apoptosis by telomestatin in childhood neuroblastoma cellsBINZ, N; SHALABY, T; RIVERA, P et al.European journal of cancer (1990). 2005, Vol 41, Num 18, pp 2873-2881, issn 0959-8049, 9 p.Article

Is a regenerative approach viable for the treatment of COPD?HIND, Matthew; MADEN, Malcolm.British journal of pharmacology. 2011, Vol 163, Num 1, pp 106-115, issn 0007-1188, 10 p.Article

Signal transduction pathways and transcription factors as therapeutic targets in inflammatory disease: Towards innovative antirheumatic therapyTAS, Sander W; REMANS, Philip H. J; REEDQUIST, Kris A et al.Current pharmaceutical design. 2005, Vol 11, Num 5, pp 581-611, issn 1381-6128, 31 p.Article

Novel therapies in MM: from the aspect of preclinical studies : PIH: Understanding the Pathogenesis and the Evolving Treatment Paradigm for Multiple Myeloma in the Era of Novel AgentsHIDESHIMA, Teru; ANDERSON, Kenneth C.International journal of hematology. 2011, Vol 94, Num 4, pp 344-354, issn 0925-5710, 11 p.Article

Surgical innovation or surgical evolution: an ethical and practical guide to handling novel neurosurgical proceduresBERNSTEIN, Mark; BAMPOE, Joseph.Journal of neurosurgery. 2004, Vol 100, Num 1, pp 2-7, issn 0022-3085, 6 p.Article

Antisense treatment of IGF-IR induces apoptosis and enhances chemosensitivity in central nervous system atypical teratoid/rhabdoid tumours cellsD'CUNJA, J; SHALABY, T; RIUERA, P et al.European journal of cancer (1990). 2007, Vol 43, Num 10, pp 1581-1589, issn 0959-8049, 9 p.Article

Interferon-y mediated up-regulation of caspase-8 sensitises medulloblastoma cells to radio-and chemotherapyMEISTER, N; SHALABY, T; UON BUEREN, A. O et al.European journal of cancer (1990). 2007, Vol 43, Num 12, pp 1833-1841, issn 0959-8049, 9 p.Article

Bendamustine: something old, something newTAGEJA, Nishant; NAGI, Jasdeepa.Cancer chemotherapy and pharmacology. 2010, Vol 66, Num 3, pp 413-423, issn 0344-5704, 11 p.Article

The future of breast cancer: the role of prognostic factorsGRADISHAR, William J.Breast cancer research and treatment. 2005, Vol 89, pp S17-S26, issn 0167-6806, SUP1Article